Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard
Sparta Pharmaceutical Corporation, Horsham, PA, United States
Search 7 grants from Howard Sands
Search grants from Sparta Pharmaceutical Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Elucidation of molecular mechanisms and functional significance of cooperation between glucocorticoid receptor and NF-kB in the airways
Creating a 3D dynamic in vitro model of the tumor microenvironment to characteriz
Planning and Evaluation
Information Processing &the Inferior Colliculus
Neurobehavioral Effects of Intrauterine Mercury Exposure
Recently added grants:
Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells
Sphingosine-1-phosphate and cryptococcosis
Structural Vaccinology and Design of Novel Imunogens for Malaria Vaccine Development
Role of B cell activating factor in non-infectious complications of common variable immunodeficiency
Molecular Signatures of Early-Onset Neonatal Sepsis in Umbilical Cord Blood
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44NS036100-03
Application #
2771968
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (11))
Program Officer
Jacobs, Tom P
Project Start
1995-08-15
Project End
1999-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Sparta Pharmaceutical Corporation
Department
Type
DUNS #
City
Horsham
State
PA
Country
United States
Zip Code
19044
Related projects
NIH 1998
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
NIH 1997
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
Comments
Be the first to comment on Howard Sands's grant